These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 25543521)

  • 1. miR-744 is a potential prognostic marker in patients with hepatocellular carcinoma.
    Tan YL; Bai ZG; Zou WL; Ma XM; Wang TT; Guo W; Liu J; Li JS; Jie-Yin ; Zang YJ; Zhang ZT
    Clin Res Hepatol Gastroenterol; 2015 Jun; 39(3):359-65. PubMed ID: 25543521
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Up-regulation of miR-9 expression predicate advanced clinicopathological features and poor prognosis in patients with hepatocellular carcinoma.
    Cai L; Cai X
    Diagn Pathol; 2014 Dec; 9():1000. PubMed ID: 25552204
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Early-phase circulating miRNAs predict tumor recurrence and survival of hepatocellular carcinoma patients after liver transplantation.
    Ng KT; Lo CM; Wong N; Li CX; Qi X; Liu XB; Geng W; Yeung OW; Ma YY; Chan SC; Man K
    Oncotarget; 2016 Apr; 7(15):19824-39. PubMed ID: 26918346
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Expression and survival prediction of microRNA-155 in hepatocellular carcinoma after liver transplantation].
    Han ZB; Chen HY; Fan JW; Wu JY; Peng ZH; Wang ZW
    Zhonghua Yi Xue Za Zhi; 2013 Mar; 93(12):884-7. PubMed ID: 23863669
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic significance of miR-218 in human hepatocellular carcinoma and its role in cell growth.
    Tu K; Li C; Zheng X; Yang W; Yao Y; Liu Q
    Oncol Rep; 2014 Oct; 32(4):1571-7. PubMed ID: 25110121
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Decrease expression and clinicopathological significance of miR-148a with poor survival in hepatocellular carcinoma tissues.
    Ajdarkosh H; Dadpay M; Yahaghi E; Pirzaman ER; Fayyaz AF; Darian EK; Mokarizadeh A
    Diagn Pathol; 2015 Aug; 10():135. PubMed ID: 26248880
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Involvement of miR-454 overexpression in the poor prognosis of hepatocellular carcinoma.
    Zhou L; Qu YM; Zhao XM; Yue ZD
    Eur Rev Med Pharmacol Sci; 2016 Mar; 20(5):825-9. PubMed ID: 27010136
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Up-regulation of microRNA-155 promotes cancer cell invasion and predicts poor survival of hepatocellular carcinoma following liver transplantation.
    Han ZB; Chen HY; Fan JW; Wu JY; Tang HM; Peng ZH
    J Cancer Res Clin Oncol; 2012 Jan; 138(1):153-61. PubMed ID: 22071603
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic significance and anti-proliferation effect of microRNA-365 in hepatocellular carcinoma.
    Chen Z; Huang Z; Ye Q; Ming Y; Zhang S; Zhao Y; Liu L; Wang Q; Cheng K
    Int J Clin Exp Pathol; 2015; 8(2):1705-11. PubMed ID: 25973057
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Downregulation of MicroRNA-1 is Associated with Poor Prognosis in Hepatocellular Carcinoma.
    Wang X; Huang Y; Zhuang H; Qian Y; Zhao Q; Yang L; Gu H; Chen J; Guo R; Liu Y
    Clin Lab; 2015; 61(9):1331-6. PubMed ID: 26554254
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum microRNA-1 and microRNA-122 are prognostic markers in patients with hepatocellular carcinoma.
    Köberle V; Kronenberger B; Pleli T; Trojan J; Imelmann E; Peveling-Oberhag J; Welker MW; Elhendawy M; Zeuzem S; Piiper A; Waidmann O
    Eur J Cancer; 2013 Nov; 49(16):3442-9. PubMed ID: 23810247
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Low-level expression of microRNA-375 predicts poor prognosis in hepatocellular carcinoma.
    Zhou N; Wu J; Wang X; Sun Z; Han Q; Zhao L
    Tumour Biol; 2016 Feb; 37(2):2145-52. PubMed ID: 26349912
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of intragenic methylation in the TUSC1 gene as a novel prognostic marker of hepatocellular carcinoma.
    Shimizu D; Kanda M; Nomoto S; Oya H; Takami H; Hibino S; Suenaga M; Inokawa Y; Hishida M; Takano N; Nishikawa Y; Yamada S; Fujii T; Nakayama G; Sugimoto H; Koike M; Fujiwara M; Kodera Y
    Oncol Rep; 2014 Mar; 31(3):1305-13. PubMed ID: 24366000
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of microRNAs, miR-21, miR-31, miR-122, miR-145, miR-146a, miR-200c, miR-221, miR-222, and miR-223 in patients with hepatocellular carcinoma or intrahepatic cholangiocarcinoma and its prognostic significance.
    Karakatsanis A; Papaconstantinou I; Gazouli M; Lyberopoulou A; Polymeneas G; Voros D
    Mol Carcinog; 2013 Apr; 52(4):297-303. PubMed ID: 22213236
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression profile of microRNA-200 family in hepatocellular carcinoma with bile duct tumor thrombus.
    Yeh TS; Wang F; Chen TC; Yeh CN; Yu MC; Jan YY; Chen MF
    Ann Surg; 2014 Feb; 259(2):346-54. PubMed ID: 24135722
    [TBL] [Abstract][Full Text] [Related]  

  • 16. miR-21 expression predicts prognosis in hepatocellular carcinoma.
    Wang WY; Zhang HF; Wang L; Ma YP; Gao F; Zhang SJ; Wang LC
    Clin Res Hepatol Gastroenterol; 2014 Dec; 38(6):715-9. PubMed ID: 25150373
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Decrease expression of microRNA-20a promotes cancer cell proliferation and predicts poor survival of hepatocellular carcinoma.
    Fan MQ; Huang CB; Gu Y; Xiao Y; Sheng JX; Zhong L
    J Exp Clin Cancer Res; 2013 Apr; 32(1):21. PubMed ID: 23594563
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Donor miR-196a-2 polymorphism is associated with hepatocellular carcinoma recurrence after liver transplantation in a Han Chinese population.
    Xu X; Ling Q; Wang J; Xie H; Wei X; Lu D; Hu Q; Zhang X; Wu L; Zhou L; Zheng S
    Int J Cancer; 2016 Feb; 138(3):620-9. PubMed ID: 26365437
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical significance of microRNA 138 and cyclin D3 in hepatocellular carcinoma.
    Huang B; Li H; Huang L; Luo C; Zhang Y
    J Surg Res; 2015 Feb; 193(2):718-23. PubMed ID: 25439221
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metastasis-related miR-185 is a potential prognostic biomarker for hepatocellular carcinoma in early stage.
    Zhi Q; Zhu J; Guo X; He S; Xue X; Zhou J; Hu B; Li H; Chen S; Zhao H; Kuang Y
    Biomed Pharmacother; 2013 Jun; 67(5):393-8. PubMed ID: 23648054
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.